NWPF

News ArchivesRead News

Your Parkinson's News Update for the Week of 10.21.19

Monday October 21, 2019
Genetic Parkinson’s Cohorts ‘Urgently’ Need Identifying
Pharma Times
Researchers working on Parkinson’s need to “urgently identify cohorts of people with a genetic form of the disease, in order to get a plethora of trials underway”, Helen Matthews, deputy chief executive officer of The Cure Parkinson’s Trust has announced.
"At eyeforpharma’s UK Patient Summit 2019, Helen reminded that currently routine testing is not offered, and that online tests do not offer genetic counseling; two things that would help identify potential cases of genetic Parkinson’s."
When Life Gives You Parkinson’s podcast:
The Smell of Parkinson’s
MSN
This Parkinson's-specific podcast (or recorded radio) takes on the ranging topics and experiences related to life impacted by the condition. In this conversation, carepartner Joy begins with the changing scent of her husband, who had with Parkinson's, and how that observation helped whole research teams to better diagnose and understand Parkinson's.
Runner With Parkinson’s Bangs Out 351 Burpees
on Way to Finishing Chicago Marathon
Runner's World
"By the time Choi, 43, reached the finish line in 5:56:03, he had completed a total of 351 burpees in addition to running 26.2 miles on the streets of the Windy City.
The burpee run was the latest in a series of impressive physical challenges that the three-time American Ninja Warrior contestant takes on to raise awareness for Parkinson’s."
Coalition of University Researchers
to Develop a Tool to Fight Parkinson's
BizJournals
In this groundbreaking collaboration, research on a new tool for Parkinson's treatment will include: Penn Medicine, Washington University-St. Louis, the University of Pittsburgh, the University of California-San Francisco, and Yale University.
At the end of five years, the group hopes to have a radioactive tracer that will be able to detect Parkinson’s early on, and provide detailed information about progression—critical for discovering and testing new treatments.